COMMUNIQUÉS West-GlobeNewswire

Federally Qualified Health Centers May Be Making Unlawful Reports to the National Practitioner Data Bank, according to Journal of American Physicians and Surgeons
10/12/2024
TUCSON, Ariz., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Those who conduct sham peer reviews of physicians at Federally Qualified Health Centers (FQHCs) are often emboldened by the false belief that they have absolute immunity [...]
Monica Lewinsky visite le laboratoire Primeks Medical d’Agnivesh Agarwal à Istanbul
10/12/2024
ISTANBUL, 10 déc. 2024 (GLOBE NEWSWIRE) -- La militante sociale Monica Lewinsky s’est rendue à Istanbul en octobre à l’invitation d’Agnivesh Agarwal, fondateur de Primeks Medical, une entreprise de fournitures médicales [...]
Enterome’s Immunotherapy EO2463 Shows Early Clinical Response in Newly Diagnosed Follicular Lymphoma Suggesting a Potential Alternative to 'Watchful Waiting'
10/12/2024
46% objective response rate, with 15% complete responses and 31% partial responses in patients with early-stage follicular lymphoma reported at the ASH 2024 meeting. Well-tolerated treatment with no severe adverse [...]
Le CEPI et Accumulus Synergy s’associent pour renforcer l’accès équitable à l’information et accélérer l’accès aux vaccins
10/12/2024
OSLO, Norvège et BURLINGAME, Californie, 10 déc. 2024 (GLOBE NEWSWIRE) -- La plateforme innovante de partage de données d’Accumulus Synergy, basée sur le cloud, pourrait accélérer l’accès aux vaccins et à d’autres [...]
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
10/12/2024
Livestream Interview Can be Viewed Today at 10:50am ET at Benzinga All Access Live BRAINTREE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Microbot Medical ® Inc. (Nasdaq: MBOT), developer of the innovative single use [...]
COVID Non-pharmaceutical Interventions Were Harmful Authoritarian Overreach, according to Journal of American Physicians and Surgeons
10/12/2024
TUSCON, Ariz., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Historically, the apocalyptic chaos that accompanied plagues provided evildoers with opportunities for exploitation, but unlike with COVID-19, the impact of those abuses [...]
Thought Leadership & Innovation Foundation Celebrates the Launch of Autism Knowledge Gateway
10/12/2024
MCLEAN, Va., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, proudly hosted " An [...]
Neuronetics and Greenbrook TMS Announce Closing of Transaction
10/12/2024
MALVERN, Pa. and TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”, and together with Neuronetics, the “Combined Company [...]
Soda Health Adds Walgreens to Network of Integrated Retailers, Serving More than 100 Million Medicare Advantage and Medicaid Members
10/12/2024
DEERFIELD, Ill. and BENTONVILLE, Ark., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Soda Health today announced the expansion of the Soda Health Smart Benefits program to include Walgreens, the leading integrated independent [...]
Brain Cancer Canada Awards a $50,000 Grant to Discover How to Use the Body’s Own Immune Cells to Attack Pediatric Brain Cancers
10/12/2024
TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is excited to announce a $50,000 grant awarded to Dr. Shawn Beug, Scientist at the Children’s Hospital of Eastern Ontario Research Institute, and his team. [...]
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
10/12/2024
TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the closing of its previously announced underwritten public offering (the “ [...]
Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024
10/12/2024
75% (12/16) complete response (CR) rate observed in standard of care (Dara-CyBorD) relapsed/refractory AL Amyloidosis patients with median 4 lines of prior therapy in updated Phase 1/2 data as of December 9, 2024 Best [...]
India’s First CDSCO Certified Robotic System for Telesurgery: SSi Mantra Leads the Way
10/12/2024
SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement [...]
HWH International Inc. and Guangzhou Inbot Technology Ltd Announce Strategic Partnership to Drive Global Robotics Expansion
10/12/2024
BETHESDA, MD, Dec. 10, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) is proud to announce the signing of a strategic partnership agreement with Guangzhou Inbot Technology Ltd, a robotics company [...]
BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health
10/12/2024
LAS VEGAS, Dec. 10, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives, Inc. (OTC: BDPT) is thrilled to announce the launch of Xcellara™ Stem Cell Activator, a groundbreaking supplement that harnesses the extraordinary [...]
UPDATE – Health-ISAC Bestows Newly Renamed Steve Katz Hero Award
10/12/2024
Rachel James received the cybersecurity threat sharing award ORMOND BEACH, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Information Sharing and Analysis Center ( Health-ISAC ), the non-profit world-class, industry-led [...]
WeightWatchers Unveils Next-Gen Program With AI-Powered App Features
10/12/2024
With access to Registered Dietitians, 150+ New ZeroPoint® Foods and smarter tracking features, the new program delivers a cutting-edge, flexible approach to holistic weight management NEW YORK, Dec. 10, 2024 (GLOBE [...]
Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium
10/12/2024
– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients previously treated with a CDK4/6 inhibitor – – Safety [...]
Visory Health Joins Fast Company's Esteemed 2024 Brands That Matter List
10/12/2024
The health tech company is honored to receive an award for its solution to make affordable medications accessible to everyone ESTERO, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Visory Health , a patient-first health tech [...]

Pages